Work

Cerebrospinal fluid CXCL10 is associated with the presence of low level CSF HIV during suppressive antiretroviral therapy

Year: 2021

Type: article

Study design: Observational Study

Source: Journal of Neuroimmunology

DOI: 10.1016/j.jneuroim.2021.577493

Authors: Albert M. Anderson, Suprateek Kundu, Bin Tang, Florin Vaida, Oluwakemi Okwuegbuna, Daniel McClernon, Mariana Cherner, Reena Deutsch, Debra Cookson, Melanie Crescini, Igor Grant, Henrik Zetterberg, Kaj Blennow, Magnus Gisslen, Ronald J. Ellis, Scott L. Letendre

Institutions: Emory University, University of California San Diego, UK Dementia Research Institute, National Hospital for Neurology and Neurosurgery, UCL Queen Square Institute of Neurology, University College London, University of Gothenburg, Sahlgrenska University Hospital, Region Västra Götaland

Language: English

Topic: HIV Research and Treatment

Subfield: Virology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Institute on Aging, National Institute of Mental Health, National Institute on Drug Abuse, National Institute of Allergy and Infectious Diseases

Awards: G183157880, HIV Neurocognitive Disorders: A Randomized Clinical Trial of CNS-Targeted HAART, G3350118538, G3715862790, G427239757, Study of zidovudine addition in HIV-associated neurocognitive disorders, G7110194617, Midcareer Investigator Award in Patient-Oriented NeuroAIDS Research, G8082634503, HIV Neurobehavioral Research Center, Center for AIDS Research at Emory University

OpenAlex ID: W3122867007

FWCI: 0.618

Cites: 31

Cited by: 7

Related to: 10